Company Overview

Update
Headquarters:
San Carlos, CA
Funding:
$48.70M
Categories:
Biotechnology

Cellerant Therapeutics is a biotechnology company offering products for the regulation of the hematopoietic system.

Description

Update

Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.

Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.

Current Team (8)

Update

Board Members and Advisors (4)

Update

Funding Rounds (8) - $48.70M

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • HQ

    1561 Industrial Road

    San Carlos, CA 94070

    USA